Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Amicus Therapeutics (FOLD) over the last 15 years, with Sep 2025 value amounting to 0.71.

  • Amicus Therapeutics' Asset Utilization Ratio rose 10.61% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 10.61%. This contributed to the annual value of 0.68 for FY2024, which is 27.13% up from last year.
  • Latest data reveals that Amicus Therapeutics reported Asset Utilization Ratio of 0.71 as of Q3 2025, which was down 0.09% from 0.71 recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Asset Utilization Ratio registered a high of 0.71 during Q2 2025, and its lowest value of 0.31 during Q1 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.62 (2024), whereas its average is 0.60.
  • Data for Amicus Therapeutics' Asset Utilization Ratio shows a peak YoY spiked of 35.23% (in 2022) over the last 5 years.
  • Over the past 5 years, Amicus Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.33 in 2021, then soared by 35.23% to 0.44 in 2022, then grew by 16.72% to 0.52 in 2023, then increased by 29.79% to 0.67 in 2024, then climbed by 10.61% to 0.71 in 2025.
  • Its last three reported values are 0.71 in Q3 2025, 0.71 for Q2 2025, and 0.69 during Q1 2025.